Sanofi’s $1B Amunix acquisition aims for targeted, safer T cell engagers for cancer
In acquiring Amunix, Sanofi becomes the latest big pharmaceutical company to strike a deal to gain access to technology that improves the safety and efficacy […]
In acquiring Amunix, Sanofi becomes the latest big pharmaceutical company to strike a deal to gain access to technology that improves the safety and efficacy […]
Specialty drugs represent a growing share of overall pharmaceutical sales, and Omnicell is acquiring specialty pharmacy technologies company ReCept Pharmacy to enter into this market. […]
ChemoCentryx has spent decades developing oral alternatives to injectable and infused biologic drugs that treat chronic autoimmune conditions. The research finally paid off with FDA […]
The startup, which says it uses “digital twins” to help people manage their diabetes, recently raised a series C round led by ICONIQ Growth. It […]
The digital health startup received FDA clearance for its carbon monoxide sensor to be used for smoking cessation without oversight from a healthcare provider. The […]
Copyright © 2024 | WordPress Theme by MH Themes